Estrogen receptor βΔ6 (ERβΔ6) isoform in human endometrial hyperplasia and adenocarcinoma

Cancer Investigation

Volumn 22, Issue 2, 2004, Pages 211-218

  Paul, Monika ^a   Cholewa, Krzysztof ^a   Mazurek, Urszula ^a   Witek, Andrzej ^a   Wilczok, Tadeusz ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

DNA sequence analysis; Endometrium; ER 6 isoform; Estrogen receptor; Real time PCR; WtER

Indexed keywords

DNA; ESTROGEN RECEPTOR BETA; MESSENGER RNA; RNA;

ADENOCARCINOMA; ADULT; AGED; ARTICLE; DNA BINDING; ENDOMETRIUM; ENDOMETRIUM CARCINOMA; ENDOMETRIUM HYPERPLASIA; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; NUCLEOTIDE SEQUENCE; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION;

ADENOCARCINOMA; ADULT; AGED; BASE SEQUENCE; CELL DIVISION; ENDOMETRIAL HYPERPLASIA; ENDOMETRIAL NEOPLASMS; ENDOMETRIUM; ESTROGEN RECEPTOR BETA; FEMALE; HUMANS; MIDDLE AGED; MOLECULAR SEQUENCE DATA; POLYMERASE CHAIN REACTION; RECEPTORS, ESTROGEN; RNA, MESSENGER; SEQUENCE ANALYSIS, DNA;

EID: 2642512418     PISSN: 07357907     EISSN: None     Source Type: Journal    
DOI: 10.1081/CNV-120030209     Document Type: Article

References (40)

1. Bockman, J.V. Two pathogenetic types of endometrial carcinoma. Gynecol. Oncol. 1983, 15, 10-17.
2. Jeyarajaah, A.; Oram, D.; Jacobs, I. Molecular events in endometrial carcinogenesis. Int. Gynecol. Cancer 1996, 6, 425-438.
3. Sherman, M.E. Theories of endometrial carcinogenesis: a multidisciplinary approach. Mod. Path. 2000, 13, 295-308.
4. Gurin, Ch.C.; Federici, M.G.; Kang, L.; Boyd, J. Causes and consequences of microcatellite in endometrial carcinoma. Cancer Res. 1999, 5, 9462-9466.
5. Risinger, J.I.; Hayes, A.K.; Maxwell, G.L.; Corney, R.K.; Dodge, J.C.; Barret, A.; Berchuck, A. PTEN mutations in endometrial cancer is associated with Favourable clinical and pathologic characteristics. Clin. Cancer Res. 1998, 4, 3005-3010.
6. Ikeda, T.; Yoshinag, S.; Semba, S.; Kondo, E.; Ohmari, H.; Horii, A. Mutational analysis of the CTNNB1 (beta-catenin) gene in human endometrial and serous carcinoma. Cancer 2000, 88, 814-824.
7. Lax, S.F.; Kendal, B.; Taschiro, H.; Slebas, R.J.; Ellenson, L.H. The frequency of p53, K-ras mutations, and microsatellite instability differs in uterine endometroid and serous carcinomas. Nat. Genet. 1997, 17, 143-144.
8. Ehrlich, C.E.; Young, P.C.M.; Stehman, F.B.; Sutton, G.P.; Alford, W.M. Steroid receptors and clinical outcome in patients with adenocarcinoma of the endometrium. Am. J. Obstet. Gynecol. 1988, 158, 796-807.
9. Utsunomiya, H.; Suzuki, T.; Harada, N.; Ito, K.; Matsuzaki, S.; Konno, R.; Sato, S.; Yajima, A.; Susano, H. Analysis of estrogen receptor alpha and beta in endometrial adenocarcinomas: correlation with ERbeta and clinicopathologic findings in 45 cases. Int. J. Gynecol. Pathol. 2000, 19 (4), 335-341.
10. Gustafsson, J.-A. Estrogen receptor β - a new dimension in estrogen mechanism of action. J. Endocrinol. 1999, 163, 379-383.
11. Mc Inerney, E.M.; Weis, K.E.; Sun, J.; Mosselman, S.; Katzenellenbogen, B.S. Transcription activation by the human estrogen receptor subtype β (ERβ) studies with ERβ and ERα receptor chimeras. Endocrinology 1998, 139 (11), 4513-4522.
12. Lubahn, D.B.; Moyer, J.S.; Golding, T.S.; Cause, J.F.; Korach, K.S.; Smithies, O. Alteration of reproductive function but not prenatal sexual development after insertional disruption of the mouse estrogen receptor gene. Proc. Natl. Acad. Sci. U.S.A. 1993, 90 (23), 11162-11166.
13. Couse, J.F.; Lindzey, J.; Grandien, K.; Gustafsson, J.-C.; Korach, K.S. Tissue distribution and quantitative analysis of estrogen receptor-alpha (ERalpha) and estrogen receptor-beta (ERbeta) messenger ribonucleic acid in the wild-type and ERalpha knockout mouse. Endocrinology 1997, 138 (11), 4613-4621.
14. Speroff, L. A clinical understanding of the estrogen receptor. Ann. N.Y. Acad. Sci. 2000, 900, 26-39.
15. Paige, L.A.; Christensen, D.J.; Gron, H.; Norris, J.D.; Gottlin, E.B.; Padilla, K.M.; Chang, C.-Y.; Ballas, L.M.; Hamilton, P.T.; McDonnell, D.P.; Fowlkes, DM. Estrogen receptor (ER) modulators each induce distinct conformational changes in ER alpha and ERbeta. Proc. Acad. Sci. U.S.A. 1999, 96 (7), 399-4004.
16. Katzenellenbogen, B.S.; Korach, K.S. Editional: a new actor in the estrogen receptor drama-enter ERβ. Endocrinology 1997, 138, 861-862.
17. Enmark, E.; Gustafsson, J.A. Estrogen receptor β - a novel receptor opens up new possibilities for cancer diagnosis and treatment, endocrine related. Cancer 1998, 5, 213-222.
18. Cowley, S.M.; Hoare, S.; Mosselman, S.; Parker, M.G. Estrogen receptors alfa and beta form heterodimers on DNA. J. Biol. Chem. 1997, 272 (32), 19858-19862.
19. Jarvinen, T.A.H.; Pelto-Huikko, M.; Holli, K.; Isola, J. Estrogen receceptor β is coexpressed with ERα and PR and associated with nodal status, grade, and proliferation rate in breast cancer. Am. J. Pathol. 2000, 156, 29-35.
20. Weihua, Z.; Saji, S.; Makinen, S.; Cheng, G.; Jensen, E.V.; Warner, M.; Gustafsson, J.-A. Estrogen receptor (ER) beta a modulator of ERalpha in the uterus. Proc. Natl. Acad. Sci. U.S.A. 2000, 97 (11), 5936-5941.
21. Gotteland, M.; Desauty, G.; Delarue, J.C.; Liu, L.; May, E. Human estrogen receptor messenger RNA variants in both normal and tumor breast tissues. Mol. Cell. Endocrinol. 1995, 112 (1), 1-13.
22. Moore, J.T.; McKeed, D.; Slent-Kesler, K.; Moore, L.; Jones, S.; Horn, E.; Su, J.; Kliewer, S.; Lehmann, J.; Willson, T. Cloning and characterization of human estrogen receptor beta isoforms. Biochem. Biophys. Res. Commun. 1998, 247, 75-78.
23. Pedersen, S.B.; Bruun, J.M.; Hube, F.; Kristensen, K.; Hauner, H.; Richelsen, B. Demonstration of estrogen receptor subtypes alpha and beta in human adipose tissue: influence of adipose cell differentiation and fat depot localization. Mol. Cell. Endocrinol. 2001, 27-37.
24. Inoue, S.; Ogawa, S.; Horie, K.; Hoshino, S.; Goto, W.; Hosoi, T.; Tsutsumi, O.; Muramatsu, M.; Ouchi, Y. An estrogen receptor beta isoforms that lacks exon 5 has dominant negative activity on both ERalfa and ERbeta. Biochem. Biophys. Res. Commun. 2000, 279, 814-819.
25. Ogawa, S.; Inoue, S.; Orimo, A.; Hosoi, T.; Ouchi, Y.; Muramatsu, S. FEBS Lett. 1998, 423 (2), 129-132.
26. Bolling, A.; Miksicek, R.J. An estrogen receptor-alpha splicing variant mediates both positive and negative effects on gene transcription. Mol. Endocrinol. 2000, 14, 634-649.
27. Pike, A.C.W.; Brzozowski, A.M.; Hubbard, R.E.; Bonn, T.; Thorsell, A.-G. ; Engstroom, O.; Ljunggren, J.; Gustafsson, J.-A.; Carlquist, M. Structure of the ligand-binding domain of oestrogen receptor beta in the presence of a partial agonist and full antagonist. EMBO J. 1999, 18, 4608-4618.
28. Horvath, G.; Leser, G.; Hahlin, M.; Henriksson, M. Exon deletions and variants of human estrogen receptor mRNA in endometrial hyperplasia and adenocarcinoma. Int. J. Gynecol. Cancer 2000, 10, 128-136.
29. Lemieux, P.; Fuqua, S. The role of the estrogen receptor in tumor progression. J. Steroid Biochem. Mol. Biol. 1996, 56, 87-91.
30. Shupnik, M.A.; Pitt, L.K.; Soh, A.Y.; Anderson, A.; Lopes, M.B.; Laws, E.R. Selective expression of estrogen receptor alpha and beta isoforms in human pituitary tumors. J. Clin. Edocrinol. Metab. 1998, 83, 3965-3972.
31. Hall, J.M.; McDonnell, D.P. The estrogen receptor β-isoform (ERβ) of the human estrogen receptor modulates ERα transcriptional activity and it's a key regulator of the cellular response to estrogen and antiestrogens. Endocrinology 1999, 140, 5566-5578.
32. Sivridis, E.; Giatromanolaki, A.; Koukourakis, M.; Anastasidis, P. Endometrial carcinoma: association of steroid hormone receptor expression with low angiogenesis and bcl-2 expression. Virchows Arch. 2001, 438, 470-477.
33. Navari, J.R.; Roland, P.Y.; Keh, P.; Salvesen, H.B.; Akslen, L.A.; Iversen, O.E.; Das, S.; Kothari, R.; Howey, S.; Philips, B. Loss of estrogen receptor (ER) expression in endometrial tumors is not associated with de novo methylation of 5′ end of the ER gene. Clin. Cancer Res. 2000, 6, 4026-4032.
34. Sivridis, E.; Giatromanolaki, A. Prognostic aspects on endometrial hyperplasia and neoplasia. Virchows Arch. 2001, 439, 118-126.
35. Poola, J.; Abraham, J.; Baldwin, K. Identification of ten exon deleted ERbeta mRNAs in human ovary, breast, uterus and bone tissues: alternate splicing pattern of estrogen receptor beta mRNA in distinct from that of estrogen receptor alpha. FEBS Lett. 2002, 516, 133-138.
36. Latil, A.; Bieche, J.; Vidaud, D.; Lidereau, R.; Berthon, P.; Cussenot, O.; Vidaud, M. Evaluation of androgen, estrogen (ERα and ERβ), and progesterone receptor expression in human prostate cancer by real-time quantitative reverse transcription-polymerase chain reaction assays. Endocrinology 2001, 61, 1919-1926.
37. Omoto, Y.; Kobayashi, S.; Inoue, S.; Ogawa, S.; Toyama, T.; Yamashita, H.; Muramatsu, M.; Gustafsson, J.A.; Iwase, H. Evaluation of oestrogen receptor beta wild-type and variant protein expression, and relationship with clinicopathological factors in breast cancers. Eur. J. Cancer 2002, 38, 380-386.
38. Lazennec, G.; Bresson, D.; Lucas, A.; Chauveau, C.; Vignon, F. ER beta inhibits proliferation and invasion of breast cancer cells. Endocrinology 2001, 142 (9), 4120-4130.
39. Brandenberger, A.; Tee, M.K.; Jaffe, R.B. Estrogen receptor alfa (ER-α) and beta (ER-β) mRNAs in normal ovary, ovarian serous cystadenocarcinoma and ovarian cancer cell lines: down-regulation of ER-β in neoplastic tissue. J. Clin. Endocrinol. Metab. 1998, 83 (3), 1025-1028.
40. Iwao, K.; Miyoshi, Y.; Egawa, Ch.; Ikeda, N.; Noguchi, S. Quantitative analysis of estrogen receptor-β mRNA and its variants in human breast cancer. Int. J. Cancer 2000, 88, 733-738.